文献速递主动脉疾病

高容量单中心开窗腔内主动脉修复术中Be Graft桥接支架的结局及当前证据概述

Outcome of the Be Graft Bridging Stent in Fenestrated Endovascular Aortic Repair in a High-Volume Single Center and an Overview of Current Evidence.
PubMed 文献 · J Endovasc Ther · 2024-02-23

回顾性单中心研究纳入2018年9月至2022年12月连续113例复杂腹主动脉瘤或胸腹主动脉瘤患者,共440个靶血管,其中361个使用BeGraft作为桥接支架,技术成功率99.4%,30天靶血管不稳定率0.27%,中位随访20个月不稳定率0.8%,1、2、3年免于靶血管不稳定分别为99.3%、98.8%、98.8%,结论支持BeGraft作为开窗腔内修复的桥接支架。

要点

  • BeGraft桥接支架技术成功率99.4%(359/361)。
  • 30天靶血管不稳定率0.27%(1/361),中位随访20个月不稳定率0.8%(3/361)。
  • 1、2、3年免于靶血管不稳定分别为99.3%、98.8%、98.8%。

核心结论

  • 靶血管不稳定的早期和中期结果令人满意,支持BeGraft作为复杂腹主动脉瘤和胸腹主动脉瘤开窗腔内修复的桥接支架。
  • 作者认为BeGraft作为开窗腔内修复的桥接支架具有高技术成功率和低早中期不稳定率,支持其作为标准桥接支架使用。

研究设计与样本

  • 回顾性单中心研究,纳入2018年9月至2022年12月连续因复杂腹主动脉瘤或胸腹主动脉瘤行开窗腔内修复且至少一个靶血管植入BeGraft外周支架作为主要桥接支架的患者。
  • 共纳入113例患者(93例男性,平均年龄71.1±9.7岁)和440个靶血管(14个扇形支架和426个开窗)。
  • 440个靶血管中406个接受初次支架植入,其中88.9%(n=361)使用BeGraft(腹腔干67、肠系膜上动脉98、右肾动脉97、左肾动脉99)。

主要发现

  • 技术成功率为99.4%(359/361)。
  • 30天靶血管不稳定率为0.27%(1/361),发生一例早期肾动脉闭塞。
  • 中位随访20个月(6-32)期间靶血管不稳定率为0.8%(3/361)。
  • 1年、2年和3年免于靶血管不稳定分别为99.3%、98.8%和98.8%。

临床怎么用

  • 作者认为BeGraft作为开窗腔内修复的桥接支架具有高技术成功率和低早中期不稳定率,支持其作为标准桥接支架使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fenestrated endovascular aneurysm repair (FEVAR) has become one of the standard treatment options for complex abdominal aortic aneurysms (cAAAs) and thoraco-abdominal aortic aneurysms (TAAAs). Despite technological advances in the main endograft design, the lack of dedicated bridging stent-grafts (BSGs) is still the Achilles heel of the procedure. The aim of this study was to evaluate the mid-term outcomes of the BeGraft stent-graft as a dedicated bridging stent for FEVAR and to review the current evidence in literature. METHODS: Retrospective single center study, including all consecutive FEVARs performed between September 2018 and December 2022 for the treatment of cAAAs and TAAAs with implantation of at least one BeGraft peripheral as the main BSG in one of the target vessels (TVs). Primary endpoints were technical success and TV instability of TV bridged with a BeGraft stent, as well as 30-day mortality and re-intervention rates. Secondary endpoints were follow-up TV instability, re-interventions, and mortality. RESULTS: A total of 113 patients (93 male, mean age 71.1±9.7) and 440 TV (14 scallops and 426 fenestrations) were included. Of the 440 TV, 406 received primary stenting. Be Grafts were used in 88.9% of these (n=361; celiac trunk [CT]=67, superior mesenteric artery [SMA]=98, right renal artery [RRA]=97, and left renal artery [LRA]=99). The technical success rate was 99.4% (359/361). The 30-day TV instability rate was 0.27% (1/361) with one early renal artery occlusion. During a median follow-up of 20 months (6-32), TV instability rate was 0.8% (3/361). Freedom from TV instability was 99.3%, 98.8%, and 98.8% at 1, 2, and 3 years, respectively. CONCLUSION: Early-term and mid-term results regarding TV instability are satisfactory and support the use of BeGraft as BSG in FEVAR for cAAAs and TAAAs.Clinical ImpactThe findings of the current study show that the use of the BeGraft stent graft as bridging stent in FEVAR is associated with a high technical success and low early and mid-term instability rate and support the standard use as a bridging stent in fenestrated aneurysm repair.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Becker D, Fernandez Prendes C, Stana J, et al. Outcome of the Be Graft Bridging Stent in Fenestrated Endovascular Aortic Repair in a High-Volume Single Center and an Overview of Current Evidence. J Endovasc Ther. 2024. PMID: 38400539. doi:10.1177/15266028241231882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。